Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 3/20 | 0.47 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11069547 | 0.86 | ALDH1A1 (0.44) | CETPMAPK1TSHRALDH1A1CYP3A4 | |
| SCHEMBL9861937 | 0.77 | CETP (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL11431937 | 0.77 | CETP (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL11529935 | 0.77 | CETP (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL11305016 | 0.77 | CETP (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL9637850 | 0.77 | TSHR (0.48) | MAPK1TP53TSHRALDH1A1TDP1 | |
| SCHEMBL17529741 | 0.76 | DNM1 (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL17529895 | 0.76 | DNM1 (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL8662023 | 0.76 | DNM1 (0.46) | CETPDNM1MEN1KMT2AMAPK1 | |
| SCHEMBL6250346 | 0.76 | DNM1 (0.46) | CETPDNM1MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020002222-A1 | PHOSPHORUS-CONTAINING ANTIOXIDANT STABILIZED AGAINST HYDROLYSIS | CHI MEI CORPORATION (TW) | 2002-01-03 | — | — | US | disclosed |
| US-4305839-A | PHOSPHITES AND PHOSPHONITES FOR COLOR STABILITY | CARSTAB CORPORATION (US) | 1981-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020002222-A1 | PHOSPHORUS-CONTAINING ANTIOXIDANT STABILIZED AGAINST HYDROLYSIS | LPO, GPX4, GPX1 | CETP 268/4885DNM1 2791/4885MEN1 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.